Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Taro Pharmaceutical Industries has received final approval from the FDA for its abbreviated new drug application for cetirizine hydrochloride oral solution, 1mg/1mL.
Subscribe to our email newsletter
The product will be marketed by Taro’s US affiliate, Taro Pharmaceuticals USA.
Taro’s cetirizine oral solution is bioequivalent to McNeil Consumer Healthcare’s Zyrtec oral solution. Cetirizine oral solution is an over-the-counter antihistamine used for the relief of sneezing, runny nose, itchy, watery eyes and itchy throat or nose due to indoor and outdoor allergies and for the relief of itching due to hives.